BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28987672)

  • 1. Volume fractions of DCE-MRI parameter as early predictor of histologic response in soft tissue sarcoma: A feasibility study.
    Xia W; Yan Z; Gao X
    Eur J Radiol; 2017 Oct; 95():228-235. PubMed ID: 28987672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Voxel-wise imaging analysis method for early evaluation of tumor treatment response].
    Chen L; Xia W; Gao X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Jun; 33(3):538-44. PubMed ID: 29709156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of temporal parameters of DCE-MRI on the quantification of heterogeneity in tumor vascularization.
    Crombé A; Saut O; Guigui J; Italiano A; Buy X; Kind M
    J Magn Reson Imaging; 2019 Dec; 50(6):1773-1788. PubMed ID: 30980697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
    Guo W; Zhang Y; Luo D; Yuan H
    Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Soft Tissue Sarcoma Response to Preoperative Chemoradiotherapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Huang W; Beckett BR; Tudorica A; Meyer JM; Afzal A; Chen Y; Mansoor A; Hayden JB; Doung YC; Hung AY; Holtorf ML; Aston TJ; Ryan CW
    Tomography; 2016 Dec; 2(4):308-316. PubMed ID: 28066805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
    Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
    Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCE-MRI-Derived Volume Transfer Constant (K
    Ye ZM; Dai SJ; Yan FQ; Wang L; Fang J; Fu ZF; Wang YZ
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618765254. PubMed ID: 29642773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?
    Hirschmann A; van Praag VM; Haas RL; van de Sande MAJ; Bloem JL
    Eur Radiol; 2020 Sep; 30(9):4724-4733. PubMed ID: 32314057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade?
    Li X; Wang Q; Dou Y; Zhang Y; Tao J; Yang L; Wang S
    Skeletal Radiol; 2020 Nov; 49(11):1829-1838. PubMed ID: 32519183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
    Lang N; Su MY; Xing X; Yu HJ; Yuan H
    J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.
    Meyer JM; Perlewitz KS; Hayden JB; Doung YC; Hung AY; Vetto JT; Pommier RF; Mansoor A; Beckett BR; Tudorica A; Mori M; Holtorf ML; Afzal A; Woodward WJ; Rodler ET; Jones RL; Huang W; Ryan CW
    Clin Cancer Res; 2013 Dec; 19(24):6902-11. PubMed ID: 24132922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
    Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor response.
    Crombé A; Le Loarer F; Cornelis F; Stoeckle E; Buy X; Cousin S; Italiano A; Kind M
    Eur Radiol; 2019 Feb; 29(2):545-555. PubMed ID: 30039222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
    Sun NN; Ge XL; Liu XS; Xu LL
    Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis.
    Hirashima Y; Yamada Y; Tateishi U; Kato K; Miyake M; Horita Y; Akiyoshi K; Takashima A; Okita N; Takahari D; Nakajima T; Hamaguchi T; Shimada Y; Shirao K
    Int J Cancer; 2012 May; 130(10):2359-65. PubMed ID: 21780098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
    Sun NN; Liu C; Ge XL; Wang J
    Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.